Company news

Altimmune, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Altimmune and the University of Alabama at Birmingham Announce Potent Respiratory Mucosal T Cell Responses in Preclinical Study of Single-Dose Intranasal COVID-19 Vaccine Candidate, AdCOVID™

August 24, 2020

Altimmune Announces Second Quarter 2020 Financial Results and Provides a Business Update

August 10, 2020

Altimmune to Announce Second Quarter 2020 Financial Results on August 12

August 4, 2020

Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID™, its Single Dose Intranasal Vaccine Candidate for COVID-19

July 21, 2020

Altimmune Announces Closing of $132 Million Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option

July 15, 2020

Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

July 12, 2020

Altimmune Announces Pricing of a Public Offering of $115 Million of Common Stock and Pre-Funded Warrants

July 12, 2020

Altimmune Signs Teaming Agreement with DynPort Vaccine Company on U.S. Government Funding Efforts for its COVID-19 Vaccine Candidate, AdCOVID™

July 8, 2020

Altimmune Announces Dosing of First Patient in Phase 1b Clinical Trial of NasoShield™, a Single Dose Intranasal Anthrax Vaccine Candidate

June 29, 2020

Altimmune Receives Award from U.S. Department of Defense to Fund Phase 1/2 Clinical Trial of T-COVID™ in Outpatients with Early COVID-19

June 28, 2020

Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B

June 21, 2020

Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19

May 31, 2020

Altimmune Announces First Quarter 2020 Financial Results and Provides a Business Update

May 12, 2020

Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. to its Board of Directors

May 11, 2020

Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine

March 29, 2020

Altimmune Announces Financial Results for the Year Ended December 31, 2019 and Provides a Corporate Update

March 26, 2020

Altimmune to Announce Year End 2019 Financial Results on March 27

March 24, 2020

Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine

February 27, 2020

Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal Cancer

January 22, 2020

Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update

November 12, 2019

Altimmune to Announce Third Quarter 2019 Financial Results on November 14

November 5, 2019

Altimmune Appoints M. Scott Harris, M.D. as Chief Medical Officer

September 8, 2019

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update

March 31, 2019

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 27 decks. Every deck is listed under its year.